3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
15
Nasopharyngeal Carcinoma
8
Lung Neoplasms
7
Uterine Cervical Neoplasms
3
Melanoma
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Nasopharyngeal Neoplasms
2
Lymphoma, T-Cell
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Radiation Injuries
1
Quality of Life
1
Osteosarcoma
1
Non-squamous Non-small Cell Lung Cancer
1
Neuroblastoma
1
Lymphoma, T-Cell, Peripheral
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Esophageal
1
Carcinoma, Hepatocellular
1
Bone Neoplasms
1
Advanced Pancreatic Cancer
1
Advanced Gastric Cancer
1
Advanced Colorectal Cancer
1
Interventions
Cyclophosphamide
30
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
21
Prednisone
20
Etoposide
20
Vincristine
16
Whole-Body Irradiation
15
Doxorubicin
15
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
14
romidepsin
13
Mycophenolic Acid
12
Lenalidomide
12
Gemcitabine
12
Cyclosporine
10
Azacitidine
10
Brentuximab Vedotin
9
Bortezomib
9
Alemtuzumab
8
Dexamethasone
7
Methotrexate
6
Cytarabine
6
Busulfan
6
Carmustine
5
pembrolizumab
4
fludarabine
4
Vorinostat
4
Tacrolimus
4
Rituximab
4
Melphalan
4
Ifosfamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell, Peripheral
×
endostar protein
×
Clear all
NCT00974324
2010-09-15
PTCL
Fudan University
Phase 2
Unknown
15 enrolled